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ABSTRACT Chronic cough causes significant impairment in the quality of life and is often immune to
treatment. Previous studies about its persistence have focused on patients managed in special cough
clinics. Little is known about the persistence of chronic cough in unselected populations. In this
prospective follow-up study, we investigated factors that predict the persistence of cough at 12-month
follow-up in a community-based study of subjects with chronic cough.
The first e-mail survey in 2017 included a questionnaire about current cough and its risk factors. The
264 subjects who reported chronic cough were sent a follow-up questionnaire 12 months later.
The response rate was 77.7% (205 subjects), of whom 165 subjects (80.5%) still had cough in 2018. In
multivariate analysis, the following baseline factors predicted the persistence of cough at 12 months;
gastro-oesophageal reflux disease (adjusted OR (aOR) 5.02 (95% CI 1.10–22.83)), presence of a chemical
trigger (aOR 2.88 (95% CI (1.20–7.00)), duration of cough more than 1 year (aOR 2.80 (95% CI
1.27–6.22)), frequent somatic symptoms (aOR 1.31 (95% CI 1.07–1.59)), and low number of family
members (aOR 0.71 (95% CI 0.52–0.98)).
In conclusion, most patients with chronic cough still suffer from cough 1 year later. The presence of
gastro-oesophageal reflux disease is the main predictor for the persistence of cough.
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Chronic cough is a troublesome disorder in many ways. Cough is the most common reason why people
seek medical help [1, 2], it significantly decreases the quality of life [3] and individuals suffering from
chronic cough feel debilitated [4]. Two previous studies reported that 50–60% of patients with chronic
cough still suffer from the disorder 5 to 7 years after the initial evaluation [5, 6]. However, the majority of
the patients in these studies had been recruited from specialised cough clinics. As only the most severe
and long-standing forms of cough are usually managed in specialised cough clinics, these studies are prone
to bias towards over-pessimism in the prognosis of chronic cough. To the best to our knowledge, there are
no studies that have examined the persistence of chronic cough in a community-based sample.
Of the studies investigating the issue, only one could define the predictors of cough persistence. That study
reported that the possible determinants of cough persistence were chronic rhinitis or reflux disease and
mild responsiveness to histamine and severe cough responsiveness to hypertonic saline [5]. However, it is
not clear whether these predictors also apply in a population-based sample without the possibility to
special investigations like histamine and saline challenges.
In order to improve our understanding of chronic cough, it would be important to obtain up-to-date
information about the persistence and risk factors of chronic cough in a nonselected population. In this
study, we examined the factors that predicted the presence of cough at 12 months in a community-based
sample of subjects reporting chronic cough.
Methods
Study design and population
This was a prospective, observational follow-up study conducted in public service employees of two
middle-sized towns in central Finland (Kuopio and Jyväskylä; altogether 13980 employees, mean
46.6 years of age, 79.2% of whom were females). An invitation to the study and the first questionnaire
were sent via e-mail to the employees’ e-mail addresses between March and April 2017. Answers were
collected via an electronic reply form. One reminder was sent to the individuals who had not responded
within 2 weeks. A total of 3695 subjects (26.4%) responded, out of whom 419 (11.3%) reported that they
were suffering from chronic cough (>8 weeks duration). The second questionnaire was sent via e-mail in
April 2018 to all of those participants who reported suffering from chronic cough in the first inquiry in
2017 and who had provided permission for follow-up (n=264, mean age 51.7 years (9.5), 83.0% females)
(figure 1). One reminder message was sent if a subject had not responded within 2 weeks. One phone
contact was made if a subject had still not answered within 2 weeks after the reminder message.
The study was approved by the Ethics Committee of Kuopio University Hospital (289/2015). Permission
to conduct the study was obtained from town officials. An informed, written consent was obtained from
all participants.
Questionnaires
The first questionnaire sent in 2017 included questions about the subject’s household, pets, moisture
damage both in their workplace and at home, family incomes, occupation, physical activity, smoking
history, alcohol consumption, current medications, recent (within 1 month) somatic symptoms, as well as
all disorders diagnosed by a physician and general health-related questions. The questions were mainly
adapted from two previous studies, the Health Behaviour and Health Among the Finnish Adult
Population study [7] and the Finnish National FINRISK study [8]. Asthma-, rhinosinusitis- and
reflux-related symptoms were enquired by questions currently employed in epidemiological studies [9–11].
Depressive symptoms were assessed by utilising the Patient Health Questionnaire-2 [12]. The first
questionnaire also included 23 detailed cough-related questions to be filled in by subjects reporting current
cough, such as questions about the frequency of coughing bouts and cough duration, as well as the
Leicester Cough Questionnaire, which was used to measure cough-related quality of life [13]. An English
version of the Finnish questionnaire sent in 2017 is included as a supplementary file.
The second questionnaire, sent in 2018, included questions about current cough, current smoking, current
moisture damage both in the workplace and at home, current pets, and current medications. Both
questionnaires were initially tested in a preliminary sample of 25 subjects and slightly revised before the
final study.
Definitions and outcomes based on questionnaires
Chronic cough was defined as cough that had lasted more than 8 weeks [14]. Wheezing was defined as
wheezing occurring but not attributable to flu during the previous 12 months [15]. Chronic rhinosinusitis
was present if there was either nasal blockage or nasal discharge (anterior or posterior nasal drip) and
either facial pain/pressure or reduction/loss of smell for more than 3 months [10]. Gastro-oesophageal
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reflux disease was present if the individual had experienced heartburn and/or regurgitation on at least
1 day per week during the last 3 months [11]. Depression was defined as a Patient Health Questionnaire-2
score of three or more [12]. The somatic symptom sum was calculated by summing all reported somatic
symptoms except cough (including chest pain on exercise, arthralgia, back pain, toothache, leg oedema,
varicose disorder, eczema, headache, sleeplessness, depression, other mental symptoms, constipation,
diarrhoea or other gastro-intestinal symptoms, sciatica); it had a scale ranging from 0 to 14. The presence
of a chemical trigger for cough was defined as the presence of one or more of the following triggers that
would either cause or worsen the cough: exhaust fumes, poor indoor air, cigarette smoke, strong odours or
strong smells. Trigger sum was calculated by summing all of the cough triggers (including the chemical
triggers defined above, upper respiratory tract infection, subfreezing air, physical exercise, pollens, speaking
(adopted from Leicester Cough Questionnaire) or a free choice) giving a value from 0 to 12. A family
history of chronic cough was defined as the presence (now or in the past) of chronic (duration more than
8 weeks) cough in parents, sisters or brothers. The main outcome was the presence of cough in the past
2 weeks based on the questionnaire sent in 2018.
Statistical analysis
Descriptive data are presented as means and 95% confidence interval. Mann–Whitney U-test and
chi-squared test were applied when appropriate. T-tests or other parametric tests were not used because
most of the variables were not continuous or normally distributed. Table 1 shows the difference in the
number of family members between the groups utilising the Mann–Whitney U-test. The following
predictors were considered based on plausible biological associations with cough [14, 16–18]: age, sex,
body mass index, years of education, professional status, unemployment or being laid off, family income,
number of family members, pet ownership, ownership of dog and cat, exposure to moisture damage in the
home or in the workplace, smoking history, alcohol consumption (total doses per week), family history of
chronic cough, acetylsalicylic acid intolerance, the somatic symptom sum, the presence of a cough
chemical trigger, the trigger sum, the use of cough remedies, cough bout frequency, cough duration more
than 1 year (this cut-off value was defined by the Youlden index), Leicester Cough Questionnaire total
score, wheezing, chronic rhinosinusitis, and gastro-oesophageal reflux disease. Confounders present in
fewer than 10 respondents were not considered. The variables showing at least a suggestive (p<0.1)
association with the outcome variables in the bivariate analyses were included in the multivariate analysis
utilising binary logistic regression analysis with a backward-directed stepwise process. A p-value <0.05 was
Enrolments in the baseline survey in 2017 (n=13 980)
Respondents in 2017 (n=3695)
Subjects with chronic cough in 2017 (n=419)
Eligible for the follow-up survey in 2018 (n=264)
Respondents in 2018 (n=205)
Subjects with cough in 2018 (n=165) Subjects without cough in 2018 (n=40)
FIGURE 1 Flow chart of the study population.
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accepted as the level of statistical significance but results showing a suggestive association (p<0.1) were
also evaluated. All analyses were performed using SPSS version 22 for the personal computer (SPSS, Inc.,
Chicago, IL, USA).
Results
The response rate was 77.7% (205 subjects, mean age 52.1 years (9.0), 85.9% females, table 2). The
proportion of missing values was less than 1%. In 2018, 165 subjects (80.5%) reported that they were still
experiencing cough.
Table 1 presents the factors that predicted cough in 2018 in the bivariate analyses.
The following factors were associated with cough in the multivariate analyses: gastro-oesophageal reflux
disease (adjusted OR (aOR) 5.02 (95% CI 1.10–22.83)), presence of a chemical trigger (aOR 2.88 (95% CI
(1.20–7.00)), duration of cough more than 1 year (aOR 2.80 (95% CI 1.27–6.22)), frequent somatic
symptoms (aOR 1.31 (95% CI 1.07–1.59)), and low number of family members (aOR 0.71 (95% CI
0.52–0.98)) (table 3).
From 2017 to 2018, the current daily smoking status had changed from 8.3% of subjects to 6.9% of
subjects, current pet ownership from 39.7% to 41.9% of subjects and current moisture damage exposure
status from 35.1% to 11.0% of subjects. Nonetheless, the inclusion of these factors into the multivariate
analysis did not change the results.
Discussion
In the present sample consisting of a community-based subjects with chronic cough, as many as 80.5%
still were suffering from cough when assessed 12 months later. In the multivariate analysis, the five factors
TABLE 1 Differences of baseline characteristics between subjects who presented cough and those who did not develop cough
at the 12-month follow-up
Characteristic at baseline Subjects with cough at follow-up
(n=165)
Subjects without cough at follow-up
(n=40)
p-value
Somatic symptom sum 3.89 (3.50–4.28) 2.38 (1.77–2.98) <0.001
Duration of the cough episode median
(range)
12–60 months (2 months to >10 years) 2–12 months (2 months to >10 years) 0.001
Trigger sum 5.60 (5.14–6.07) 4.05 (2.98–5.12) 0.003
Presence of a chemical trigger 84.8% 65.0% 0.004
Gastroesophageal reflux disease 22.4% 7.5% 0.033
Current daily smoking 10.3% 0% 0.034
Family members 1.58 (1.40–1.76) 2.00 (1.59–2.41) 0.051
Wheezing 52.1% 37.5% 0.097
Data are presented as mean (95% CI), unless otherwise stated. Characteristics with at least a suggestive association (p<0.10) are presented
and based on chi-squared and Mann–Whitney U-tests.
TABLE 2 The characteristics at baseline of the 205 subjects who responded to the follow-up
survey in 2018
Age years mean±SD 52.1±9.0
Female sex 176 (85.9%)
Body mass index kg·m−2 mean±SD 28.1±5.6
Current smokers 17 (8.3%)
Ex-smokers 51 (24.9%)
Pet ownership 81 (39.5%)
Moisture damage in workplace or at home 72 (35.1%)












Data are presented as n (%), unless otherwise stated.
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at baseline that predicted cough at 12 months were 1) gastro-oesophageal reflux disease, 2) the presence of
a chemical trigger, 3) duration of cough more than 1 year, 4) number of somatic symptoms, and 5) a low
number of family members.
Gastro-oesophageal reflux disease was the most important predictor for persistent cough at 12 months
after the initial evaluation among patients with chronic cough. The relationship between chronic cough
and gastro-oesophageal reflux disease is rather complex and the exact pathophysiological mechanism
underpinning this relationship remains unclear [19]. In patients with chronic cough, the passage of acid
into the distal oesophagus increases the frequency of coughing [20] and elevates the cough reflex
sensitivity to capsaicin [21]. Furthermore, it has been claimed that the major determinants of the cough
seem to be the volume of the refluxate and the duration of the reflux episode rather than the acidity of the
refluxate [22]. These findings could explain why acid-suppressive therapy has proven to be ineffective in
reducing cough frequency in many placebo-controlled trials [23]. Given the fact that reflux seems to be a
strong predictor for a poor prognosis in chronic cough, its proper treatment is of fundamental importance.
According to the latest guidelines [19], the treatment of chronic cough due to gastro-oesophageal reflux
should consist of diet modification to promote weight loss in overweight or obese patients, head-of-bed
elevation and avoidance of meals 3 h before going to bed. Proton-pump inhibitors, H2-receptor
antagonists or antacid therapy are recommended for patients who report heartburn and regurgitation.
Those patients whose cough has been refractory to a 3-month trial of lifestyle and medical anti-reflux
therapy and who are being evaluated for surgical management, should undergo a 24-h oesophageal
manometry and pH-metry monitoring and if peristalsis is adequate and oesophageal acid exposure is
abnormal, anti-reflux surgery should be considered as a way of treating their chronic cough.
One may think that the under-medication of reflux in the population might explain the predictive value of
reflux symptoms. Indeed, just 25 out of 40 subjects with symptomatic reflux used proton-pump inhibitors.
However, it has been shown that the effect of any medical therapy is poor in reflux-associated cough.
Therefore, it is unlikely that under-medication of reflux symptoms explains the association between reflux
symptoms and the persistence of cough.
It should be noted that many patients with chronic cough possibly due to gastro-oesophageal reflux
disease do not have the typical symptoms associated with gastro-oesophageal reflux disease (i.e. heartburn
and regurgitation) [24]. In this study, we asked about the presence of gastro-oesophageal reflux disease
based on validated symptoms [11]. This raises the following questions: what is the prevalence of
gastro-oesophageal disease among chronic cough patients with atypical or absent reflux symptoms and
should 24-h oesophageal manometry and pH-metry be performed in all patients complaining of
unexplained chronic cough?
The presence of a chemical trigger (either exhaust fumes, poor indoor air, cigarette smoke, strong odours
or strong smells) was also a crucial predictor for persistence of cough. TERNESTEN-HASSÉUS et al. [30] have
previously shown that chemical-sensitive patients coughed significantly more on inhaling capsaicin, and
had significantly more other airway symptoms compared to those in the nonsensitive group. These
findings fit to the concept of cough hypersensitivity syndrome [25], hence presence of a chemical trigger
suggests a diagnosis of cough hypersensitivity syndrome. We think that the presence of a chemical trigger
is an important part of the anamnesis of a patient suffering chronic cough.
In this study, a duration of cough lasting more than 1 year predicted the prolongation of chronic cough
almost as strongly as the presence of a chemical trigger. The mechanism behind this finding might be
central sensitisation, such as in chronic pain. As with chronic pain, continued stimulation may result in
increased neuronal responsivity and sensitisation [26]. Given the fact that chronic cough is difficult to treat
[4–6], careful diagnostic and therapeutic management should be done in the early phase of cough.
TABLE 3 Multivariate adjusted odds ratios (aOR) between characteristics at baseline in 2017
and the presence of cough at the 12-month follow-up
Characteristic at baseline aOR (95% CI) p-value
Gastro-oesophageal reflux disease 5.02 (1.10–22.83) 0.037
Presence of a chemical trigger 2.88 (1.20–7.00) 0.018
Duration of cough more than 1 year 2.80 (1.27–6.22) 0.011
Somatic symptom sum# 1.31 (1.07–1.59) 0.008
Number of family members¶ 0.71 (0.52–0.98) 0.034
#: per individual somatic symptom; ¶: per number of family members other than the respondent.
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The number of somatic symptoms predicted the presence of cough at 12 months. It seems likely that there
are individual differences in the ways in which individuals recognise and report their symptoms, a
phenomenon called somatisation. In the present study, somatisation was taken into account by calculating
the somatic symptom sum. Previously it has been reported that there is a good association between
somatisation symptoms and asthma symptoms [27]. A lower number of family members also predicted
cough at 12 months. This is an interesting finding because the hygiene hypothesis has been proposed to lie
behind atopy and atopic disease (i.e. family size is negatively associated with atopy and atopic disease) [28]
but to the best to our knowledge, not previously with chronic cough. The protective effect of large families
in atopy and allergic diseases is considered to be explained by the greater exposure to microbes in
members of these families. The same mechanism does not necessarily explain our finding about the
protective effect of larger family size.
Interesting negative findings are that neither asthma nor chronic rhinitis predicted cough at 12 months.
These diseases had been quite well medically treated, similarly to gastro-oesophageal reflux disease (table
2). It can be postulated that asthma and chronic rhinitis are conditions that respond better to medical
treatment in contrast to gastro-oesophageal disease, which requires lifestyle modifications rather than
simply acid-suppressive therapy to effectively treat chronic cough. In addition, asthma and chronic rhinitis
tend to be seasonal and this may have influenced the failure to detect a relationship with chronic cough.
Furthermore, the Leicester Cough Questionnaire did not predict cough prolongation, suggesting that
severity of cough is not predictive for its prolongation. This is an important message to patients with
chronic cough and also to doctors treating them. There is no reason for pessimism on the basis of cough
severity at the initial evaluation.
There are several limitations to this study. The population consisted of working-age, public service
employees, so the generalizability of the study may be somewhat limited. Individuals in the lower social
classes and older persons are therefore underrepresented, and this may also partly explain the low smoking
rate. Thus, the role of smoking in cough prolongation cannot be determined in this population. It should
also be taken into account that all the data in this study are based on self-reported symptoms. Subjects
also self-reported clinical diagnoses and medications and these were not rechecked from the electronic
patient record system. Many patients with gastro-oesophageal reflux disease did not use proton-pump
inhibitors, which may have affected the results. A single year is also a rather short time in the follow-up of
chronic cough; in fact, we are well aware that the majority of cough patients may have suffered from cough
for several years [4, 29]. On the other hand, from the point of view of the patients, even suffering from
this irritating disorder for 1 year is already a long time.
The strengths of the study include the community-based sample; the previous two studies that have
examined the prognosis of chronic cough were conducted in a selected population (i.e. patients being
treated in specialised cough clinics). In addition, this study includes more patients than the previous two
studies combined [5, 6]. The strength of this study is also its prospective, follow-up design. It is recognised
that causal inference between risk factors and cough prolongation can be better investigated in a
prospective, follow-up study than in one with a cross-sectional design. The baseline questionnaire was
originally developed to investigate the risk factors of cough. Nonetheless, this questionnaire was
comprehensive, the collection of risk factors was systematic, and the response rate was good (77.7%).
In conclusion, this study is the first that has investigated the persistence of chronic cough and its risk
factors in a community-based sample. It was found that the vast majority (i.e. 80%) of patients still have
cough at the 1-year follow-up, even though asthma and chronic rhinitis had been mainly adequately
medically treated. Gastro-oesophageal reflux disease is the main indicator for cough persistence in chronic
cough. Physicians should take a careful patient history about the presence of gastro-oesophageal reflux
disease in a patient suffering from chronic cough. Treatment should be started, especially focusing on
lifestyle modifications as well as anti-reflux therapy if needed. The presence of a chemical trigger, the
duration of cough and the presence of other somatic symptoms should also be considered to get a proper
assessment of the risk factors of prolongation of chronic cough.
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